期刊文献+

原发性高血压患者醛固酮与肾素比值及夜间血压的关系分析 被引量:1

下载PDF
导出
摘要 目的探究原发性高血压患者的夜间血压与醛固酮和肾素比值(ARR)的相关关系。方法选取在我院进行治疗的123例高血压患者,根据ARR值进行分组,即ARR高水平组和ARR低水平组,将两组患者服用药物、血钠、血钾以及夜间和日间的舒张压收缩压等指标。结果两组患者的夜间舒张压和收缩压,血钠和血钾均存在明显差异(P<0.05),ARR值与日间的舒张压和收缩压、血钠呈正相关关系,与血钾呈负相关关系;且多因素Logistic回归分析结果显示夜间舒张压和收缩压和ARR值的相关因素均为相互独立,OR值分别为1.150和1.094;患者的年龄、性别、吸烟、糖尿病以及体质量指数、服用不同的降压药物以及夜间舒张压和收缩压无统计学意义(P>0.05)。结论对于原发性高血压患者,夜间血压和ARR呈现明显的相关关系。
作者 刘丽雅
机构地区 厦门市第五医院
出处 《心血管病防治知识(学术版)》 2019年第16期5-7,共3页 Prevention and Treatment of Cardiovascular Disease
  • 引文网络
  • 相关文献

参考文献3

二级参考文献35

  • 1陆星华,王丽,李辉,钱家鸣,邓瑞雪,周璐.胰腺癌相关危险因素研究及高危评分模型的建立[J].中华消化杂志,2005,25(9):515-520. 被引量:20
  • 2Yoshimoto T, Hirata Y. Aldosterone as a Cardiovascular riskhormone. Endocr,2007 ,54:359-370.
  • 3Edelmann F,Tomaschitz A,Wachter R,et al. Serum aldosteroneand its relationship to left ventricular structure and geometry inpatients with preserved left ventricular ejection fraction. Eur HeartJ,2012,33 :203-212.
  • 4Steigerwalt S,Zafar A,Mesiha N,et al. Role of aldosterone inleft ventricular hypertrophy among African-American patients withend-stage renal disease on hemodialysis. Am Nephrol,2007,27 :159-163.
  • 5Nakahara T, Takata Y, Hirayama Y, et al. Left ventricularhypertrophy and geometry in untreated essential hypertension isassociated with blood levels of aldosterone and procollagen type IEamino-terminal peptide. Circulation, 2007,71 :716-721.
  • 6Stas S, Whaley-Connell A, Habibi J,et al. Mineral ocorticoidrecept or blockade attenuates chronic over expression of the rennin-angiotensin-aldosterone system stimulation of reduced nicotinamideadenine dinucleotide phosphate oxidase and cardiacremodeling. Endocrinology ,2007 ,148 :3773-3780.
  • 7Duprez DA, Bauwens FR, De Buyzere ML, et al. Influnence ofarterial blood pressure and aldosterone on left ventricularhypertrophy in moderate essential hypertension. Am cardiol, 1993 ,71:17A-20A.
  • 8Epstein M. Aldosterone receptor blockade and the role ofepelemone: evolving perspectives. Nephrodial Transplant,2003,18:1984-1992.
  • 9Rossi GP, Ganzaroli C, Cesari M, et al. Endothelin receptorblockade lowers plasma aldosterone levels via different mechanismsin primary aldosterone and high to normal renninhypertention. Cardiovasc Res 12003 ,57 :2772-2783.
  • 10Pitt B,Zannad F,Remme WJ,et al. The effect of spironolactone onmorbidity and mortality in patients with severe heart failure.Randomized aldactone evaluation study investigators. N Engl Med,1999,341:709-717.

共引文献48

同被引文献15

二级引证文献4

相关主题

;
使用帮助 返回顶部